On Focus

Quick Map

10-12 PhD student fellowships on Biology and Pathology of the Malaria Parasite (Heidelberg) PDF Print E-mail
(0 votes, average 0 out of 5)
User Rating: / 0
Saturday, 24 April 2010 20:46

EVIMalaR is a collaborative research Network of Excellence, funded by the European Commission and coordinated by the University of Glasgow. It currently engages 49 Principal Investigators from 34 institutions in Europe (29) and malaria endemic countries (5). The consortium conducts research on malaria parasites and their interactions with both mammalian hosts and mosquito vectors. EVIMalaR’s International PhD Programme aims to train talented young scientists from both North and South in malaria research, with emphasis on interdisciplinary approaches. It thus offers a unique opportunity for students to become engaged in malaria research in world-leading malaria research institutions.

Training of the future EVIMalaR students is conducted through the virtual European Malaria Graduate School, which is organized and operated in collaboration with the EMBL and the Heidelberg University.

Applications are invited for studentships (funded for a maximum of 3.5 years) linked to collaborative research projects, each supervised by two or more principle investigators from different countries. Applicants should hold the necessary qualifications entitling them to undertake a PhD study in their host country, and should possess a high standard of written and spoken English. Applications are to be submitted online via www.evimalar.org (application system open from 8 January on) and are due by 8 March 2010. Shortlisted candidates will be invited to EMBL, Heidelberg, on 26 – 28 May 2010, for interviews with the Admissions Committee. Successful candidates should be available to start in October 2010 to attend the 3-week PhD Core Course in Heidelberg.



EVIMalaR PhD Programme
This e-mail address is being protected from spambots. You need JavaScript enabled to view it
Heidelberg University Medical School

Ansprechpartner: Miriam Griesheimer, This e-mail address is being protected from spambots. You need JavaScript enabled to view it



Comments (0)
Only registered users can write comments!